-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2018 to Q1 2023.
- Freeline Therapeutics Holdings plc Net Income (Loss) Attributable to Parent for the quarter ending 31 Mar 2023 was $1.17M.
- Freeline Therapeutics Holdings plc annual Net Income (Loss) Attributable to Parent for 2022 was -$89M, a 36.6% increase from 2021.
- Freeline Therapeutics Holdings plc annual Net Income (Loss) Attributable to Parent for 2021 was -$140M, a 45.8% decline from 2020.
- Freeline Therapeutics Holdings plc annual Net Income (Loss) Attributable to Parent for 2020 was -$96.3M, a 78.7% decline from 2019.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)